| Phone Icon 403.210.5275 | Email Icon Contact Us | Resize Text
Post Header Graphic
Category:

COVID-19 Precision Health Genomics for Children

For immediate release
May 26th, 2020, Calgary, Alberta

Children are affected by COVID-19 differently than adults. Exactly why is not clearly understood and here in Alberta researchers are working hard to find the answers.

Drs. Francois Bernier (image at left) and Jim Kellner (image at right), co-leaders of a newly funded research project, and members of the Alberta Children’s Hospital Research Institute (ACHRI) at the University of Calgary  believe that children may well hold the key to unlocking some of the mysteries to the varying degree of  severity of COVID-19 across Alberta.

The Bernier / Kellner team will be working in concert with Alberta Health Services Public Health Officers, leading clinicians and Alberta Precision Laboratories (APL) to recruit children in Alberta under the age of 18 who have been tested for the SARS-COV2 virus. Some of Alberta’s leading experts in infectious diseases, immunology, virology, genomics and public health will perform comprehensive studies to understand the role of children’s immune response. They will also look at the children’s genetic makeup to determine risk factors for severe illness and gain insight into targeted treatments. The team also hopes to identify the biological differences in the response of children to COVID-19 that may shed light on ways to better combat the effects seen in adults.

“We are grateful to Genome Alberta, and the Alberta Children’s Hospital Foundation for funding this research,” says Francois Bernier. “Investigating children’s immune system, genes, and the virus’ genes is essential to us understanding why some children become critically ill and others only mildly ill. The interplay between the virus’ genes and the immune response and genetic makeup of infected children is key. Mapping virus genetics also allows us to precisely trace how the virus is moving and spreading.” Dr. Bernier, MD, is a professor in the Departments of Medical Genetics and Paediatrics at the Cumming School of Medicine (CSM).

Dr. Jim Kellner, MD, a professor in the Departments of Pediatrics, Microbiology, Immunology & Infectious Disease and Community Health Sciences at the CSM, and an infectious disease researcher at ACHRI says “We want to better understand how contagious children are, precisely how the virus is affecting their young bodies, and how children develop immunity against COVID-19.”

Genome Alberta is one of the funders for the project and President and CEO David Bailey notes,  “This project, led by leading Calgary pediatric clinicians will generate data that will better predict the severity of the disease and thereby directly inform the care of children and adults alike. Furthermore, collaborations have been established with pediatric research teams in Toronto, Montreal and Vancouver extending the impact of this work far beyond Alberta’s borders”.

The UCalgary study, a collaboration between the University of Alberta, Alberta Health Services, the Alberta Children’s Hospital and Alberta Precision Laboratories, is funded by Genome Canada through Genome Alberta, and the Alberta Children’s Hospital Foundation through ACHRI.

                                      -------------------

Contact:

Mike Spear
Genome Alberta
Director of Communications
mspear@genomealberta.ca
Cell: 403-813-5843

 

Kelly Johnston
Media Relations, Cumming School of Medicine
University of Calgary
Cell: 403.617.8691
kelly.johnston2@ucalgary.ca

 

Karen Thomas
Alberta Children’s Hospital Research Institute
Community Engagement Manager
Cell: 403.651.1112
Karen.thomas1@ucalgary.ca

About Genome Alberta

Genome Alberta is a publicly funded not-for profit corporation which invests primarily in large-scale genome sciences research projects and technology platforms focused on areas of strategic importance to the province (e.g. human health, forestry, plant and animal agriculture, energy, and environment).  By working collaboratively with government, universities, and industry, Genome Alberta is a catalyst for a vibrant life sciences cluster with far reaching social and economic benefits for Alberta and Canada. To date, the organization has managed a research portfolio with approved budgets totaling more than $255 million.  Please visit Genome Alberta’s website for more information.

About Alberta Children’s Hospital Research Institute

The Alberta Children’s Hospital Research Institute (ACHRI) supports excellence in research, education and knowledge translation to improve the health and well-being of children and families.  A multi-disciplinary institute of the University of Calgary, Alberta Health Services and the Alberta Children’s Hospital Foundation, ACHRI researchers create new knowledge to change practice, design new treatments and shape policy to improve child health outcomes. research4kids.ucalgary.ca

About the University of Calgary

The University of Calgary is a global intellectual hub located in Canada’s most enterprising city. In our spirited, high-quality learning environment, students thrive in programs made rich by research, hands-on experiences and entrepreneurial thinking. Our strategy drives us to be recognized as one of Canada’s top five research universities, engaging the communities we both serve and lead. This strategy is called Eyes High, inspired by the university's Gaelic motto, which translates as 'I will lift up my eyes.' For more information, visit ucalgary.ca/eyeshigh

For more information, visit ucalgary.ca. Stay up to date with University of Calgary news headlines on Twitter @UCalgary. For details on faculties and how to reach experts go to our media centre at ucalgary.ca/mediacentre

COVID-19 Precision Health Genomics for Children

Listen Icon Listen to podcast